Security key
035255108
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 13,404,566
- Total 13F shares
- 13,319,121
- Share change
- +615,418
- Total reported value
- $402,798,234
- Put/Call ratio
- 167%
- Price per share
- $30.24
- Number of holders
- 152
- Value change
- +$13,754,863
- Number of buys
- 91
- Number of sells
- 54
Report period
Q1 2019
Institutions
152
Top holders
10
ANIK full security history
Newer quarter: Q2 2019
Previous quarter: Q4 2018
Anika Therapeutics, Inc. SEC filings
Anika Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 035255108
Recent filing periods:
Top shareholders of ANIK - Anika Therapeutics Inc - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BlackRock Finance, Inc. |
13F
|
Company |
16%
|
2,113,049
|
$71,020,000 | — | 31 Dec 2018 | |
| KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC |
13F
|
Company |
11%
|
1,418,605
|
$47,679,000 | — | 31 Dec 2018 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
7.4%
|
997,441
|
$33,523,000 | — | 31 Dec 2018 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.6%
|
879,651
|
$29,565,000 | — | 31 Dec 2018 | |
| STATE STREET CORP |
13F
|
Company |
3.8%
|
504,087
|
$16,942,000 | — | 31 Dec 2018 | |
| FIRST MANHATTAN CO. LLC. |
13F
|
Company |
3.1%
|
409,852
|
$13,775,000 | — | 31 Dec 2018 | |
| Engaged Capital LLC |
13F
|
Company |
2.8%
|
374,926
|
$12,601,000 | — | 31 Dec 2018 | |
| AMI ASSET MANAGEMENT CORP |
13F
|
Company |
2.4%
|
322,062
|
$10,825,000 | — | 31 Dec 2018 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2%
|
263,133
|
$8,844,000 | — | 31 Dec 2018 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.9%
|
258,494
|
$8,688,000 | — | 31 Dec 2018 | |
| Boston Trust Walden Corp |
13F
|
Company |
1.9%
|
249,537
|
$8,386,000 | — | 31 Dec 2018 | |
| THB ASSET MANAGEMENT |
13F
|
Company |
1.8%
|
236,612
|
$7,952,000 | — | 31 Dec 2018 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.5%
|
205,544
|
$6,909,000 | — | 31 Dec 2018 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.4%
|
193,606
|
$6,508,000 | — | 31 Dec 2018 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
1.4%
|
192,619
|
$6,473,000 | — | 31 Dec 2018 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
1.4%
|
190,548
|
$6,404,000 | — | 31 Dec 2018 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
1.3%
|
178,234
|
$5,990,000 | — | 31 Dec 2018 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.2%
|
161,493
|
$5,427,000 | — | 31 Dec 2018 | |
| Invesco Ltd. |
13F
|
Company |
1.2%
|
157,071
|
$5,279,000 | — | 31 Dec 2018 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
1.1%
|
144,032
|
$4,841,000 | — | 31 Dec 2018 | |
| MARSHALL WACE, LLP |
13F
|
Company |
1%
|
134,333
|
$4,515,000 | — | 31 Dec 2018 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
1%
|
133,894
|
$4,500,000 | — | 31 Dec 2018 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.94%
|
125,419
|
$4,215,000 | — | 31 Dec 2018 | |
| NATIXIS ADVISORS, LLC |
13F
|
Company |
0.93%
|
124,980
|
$4,200,000 | — | 31 Dec 2018 | |
| Portolan Capital Management, LLC |
13F
|
Company |
0.88%
|
118,509
|
$3,983,000 | — | 31 Dec 2018 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.86%
|
115,375
|
$3,878,000 | — | 31 Dec 2018 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.76%
|
102,049
|
$3,429,000 | — | 31 Dec 2018 | |
| CAPITAL MANAGEMENT CORP /VA |
13F
|
Company |
0.76%
|
101,819
|
$3,422,000 | — | 31 Dec 2018 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.68%
|
91,209
|
$3,065,000 | — | 31 Dec 2018 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.62%
|
82,837
|
$2,784,000 | — | 31 Dec 2018 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.58%
|
77,397
|
$2,602,000 | — | 31 Dec 2018 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.57%
|
76,789
|
$2,581,000 | — | 31 Dec 2018 | |
| South Dakota Investment Council |
13F
|
Company |
0.56%
|
74,421
|
$2,501,000 | — | 31 Dec 2018 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.55%
|
74,224
|
$2,495,000 | — | 31 Dec 2018 | |
| BARROW HANLEY MEWHINNEY & STRAUSS LLC |
13F
|
Company |
0.54%
|
72,177
|
$2,426,000 | — | 31 Dec 2018 | |
| UBS Group AG |
13F
|
Company |
0.53%
|
71,470
|
$2,402,000 | — | 31 Dec 2018 | |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.48%
|
64,490
|
$2,168,000 | — | 31 Dec 2018 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.47%
|
62,556
|
$2,103,000 | — | 31 Dec 2018 | |
| MORGAN STANLEY |
13F
|
Company |
0.45%
|
60,137
|
$2,021,000 | — | 31 Dec 2018 | |
| Assenagon Asset Management S.A. |
13F
|
Company |
0.42%
|
56,230
|
$1,890,000 | — | 31 Dec 2018 | |
| Foundry Partners, LLC |
13F
|
Company |
0.41%
|
55,340
|
$1,860,000 | — | 31 Dec 2018 | |
| THOMPSON SIEGEL & WALMSLEY LLC |
13F
|
Company |
0.41%
|
55,172
|
$1,855,000 | — | 31 Dec 2018 | |
| STIFEL FINANCIAL CORP |
13F
|
Company |
0.37%
|
49,075
|
$1,649,000 | — | 31 Dec 2018 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.36%
|
47,987
|
$1,613,000 | — | 31 Dec 2018 | |
| ROYAL BANK OF CANADA |
13F
|
Company |
0.32%
|
42,611
|
$1,433,000 | — | 31 Dec 2018 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.31%
|
42,172
|
$1,417,000 | — | 31 Dec 2018 | |
| Teton Advisors, Inc. |
13F
|
Company |
0.3%
|
40,000
|
$1,344,000 | — | 31 Dec 2018 | |
| Piermont Capital Management Inc. |
13F
|
Company |
0.3%
|
39,950
|
$1,343,000 | — | 31 Dec 2018 | |
| J.P. Morgan Private Wealth Advisors LLC |
13F
|
Company |
0.29%
|
38,678
|
$1,300,000 | — | 31 Dec 2018 | |
| SYSTEMATIC FINANCIAL MANAGEMENT LP |
13F
|
Company |
0.28%
|
37,485
|
$1,260,000 | — | 31 Dec 2018 |
Institutional Holders of Anika Therapeutics Inc - Common Stock (ANIK) as of Q1 2019
As of 31 Mar 2019,
Anika Therapeutics Inc - Common Stock (ANIK) was held by
152 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
13,319,121 shares.
The largest 10 holders included
BlackRock Inc., KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, DIMENSIONAL FUND ADVISORS LP, VANGUARD GROUP INC, STATE STREET CORP, AMERIPRISE FINANCIAL INC, RENAISSANCE TECHNOLOGIES LLC, D. E. Shaw & Co., Inc., BTIM Corp., and Bank of New York Mellon Corp.
This page lists
152
institutional shareholders reporting positions in this security
for the Q1 2019 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2019 vs Q4 2018 Across Filers
Q4 2018 holders
156
Q1 2019 holders
152
Holder diff
-4
| Investor | Q4 2018 Shares | Q1 2019 Shares | Share Diff | Share Chg % | Q4 2018 Value $ | Q1 2019 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.